Details for Patent: 9,265,725
✉ Email this page to a colleague
Which drugs does patent 9,265,725 protect, and when does it expire?
Patent 9,265,725 protects FINACEA and is included in one NDA.
This patent has one hundred and thirty-seven patent family members in twenty countries.
Summary for Patent: 9,265,725
Title: | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
Abstract: | The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients. The invention further relates to a foamable composition further containing a liquefied hydrocarbon gas propellant. |
Inventor(s): | Tamarkin; Dov (Maccabim, IL), Friedman; Doron (Karmei Yosef, IL), Berman; Tal (Rishon LeZiyyon, IL), Ziv; Enbal (Gedera, IL), Schuz; David (Moshav Gimzu, IL) |
Assignee: | Foamix Pharmaceuticals Ltd. (Rehovot, IL) |
Application Number: | 11/825,406 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,265,725 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 9,265,725
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,265,725
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Israel | 152486 | Oct 25, 2002 |
International Family Members for US Patent 9,265,725
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003279493 | ⤷ Try a Trial | |||
Australia | 2004261063 | ⤷ Try a Trial | |||
Australia | 2004266502 | ⤷ Try a Trial | |||
Australia | 2004313285 | ⤷ Try a Trial | |||
Australia | 2004321183 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |